文献速递运动医学关节外科

半月板同种异体移植的长期结局与移植物存活率:最低随访10年的系统评价

Long-term Outcomes and Survivorship of Meniscal Allograft Transplantation: A Systematic Review With Minimum 10-Year Follow-up.
PubMed 文献 · Am J Sports Med · 2026-01-18

该系统评价纳入13项研究共619例患者632例半月板同种异体移植(MAT),平均随访11.1至20.0年,显示Lysholm、Tegner、VAS和KOOS评分在多数研究中有统计学显著改善,10年移植物存活率为45%至100%,15年以上存活率为19%至87%。作者认为MAT长期临床结局良好但移植物存活率差异大,需继续开展前瞻性高级别研究。

要点

  • 13项研究619例患者632例MAT,平均随访11.1至20.0年,10年存活率45%至100%。
  • Lysholm评分在7/9项研究中显著改善,Tegner评分在3/4项研究中显著改善。
  • 15年以上MAT存活率为19%至87%,多数研究10年存活率≥73%。

核心结论

  • MAT在10年以上随访中显示出良好的长期临床结局,但移植物存活率存在差异。
  • 纳入研究在移植物类型、固定技术和患者选择方面存在差异。
  • 作者认为需要继续开展前瞻性高级别研究以标准化手术方式、提高该保关节干预的耐久性并识别导致长期结局不佳的可改变危险因素。

研究设计与样本

  • 系统评价与Meta分析,证据等级4级,遵循PRISMA指南并在Prospero注册。
  • 检索PubMed、Cochrane Central Register of Controlled Trials和Scopus数据库,检索时间为2025年1月。
  • 纳入评估MAT患者报告结局或客观结局且随访≥10年的研究,排除非英语研究、病例报告、非同行评议文章、社论、评论和综述。
  • 共纳入13项研究,包含619例患者和632例MAT,研究实施时间为1984年至2012年。

主要发现

  • 患者平均年龄范围为24.5至43.5岁,男性比例为47%至87%,平均随访时长为11.1至20.0年。
  • 固定技术包括软组织固定(5项研究)、骨栓固定(6项研究)和骨槽固定(4项研究)。
  • Lysholm评分在7/9项研究中显示统计学显著改善,Tegner评分在3/4项研究中显示统计学显著改善,VAS评分在3/5项研究中显示统计学显著改善,KOOS在1/1项研究中显示统计学显著改善。
  • 2项研究报告患者可接受症状状态率:Lysholm评分为70.2%至71%,KOOS为58.5%至82%。
  • 2项研究报告最小临床重要差异率:Lysholm评分为70.4%至89.9%,KOOS各子量表为61%至78.2%。

关键数值与推荐

  • MAT失败由各原始研究根据临床、手术和/或影像学标准定义。
  • 患者可接受症状状态率:Lysholm评分70.2%至71%,KOOS 58.5%至82%(2项研究)。
  • 最小临床重要差异率:Lysholm评分70.4%至89.9%,KOOS子量表61%至78.2%(2项研究)。
  • 10年MAT存活率45%至100%,≥15年存活率19%至87%。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 纳入研究在移植物类型、固定技术和患者选择方面存在差异。
  • 作者认为需要继续开展前瞻性高级别研究以标准化手术方式、提高该保关节干预的耐久性并识别导致长期结局不佳的可改变危险因素。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Meniscal allograft transplantation (MAT) is an emerging treatment for patients with symptomatic meniscal deficiency. PURPOSE: To systematically evaluate the long-term clinical outcomes and graft survivorship of MAT with a minimum follow-up of 10 years. STUDY DESIGN: Systematic review and meta-analysis; Level of evidence, 4. METHODS: A review was conducted following PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) guidelines and registered on Prospero. The PubMed, Cochrane Central Register of Controlled Trials, and Scopus databases were queried in January 2025. Studies assessing MAT patient-reported or objective outcomes with ≥10 years of follow-up were included. Non-English-language studies, case reports, non-peer-reviewed articles, editorials, commentaries, and reviews were excluded. The Lysholm score, Tegner Activity Scale score, visual analog scale (VAS) for pain score, Knee injury and Osteoarthritis Outcome Score (KOOS), and graft survivorship were extracted for analysis. MAT failure was defined by individual studies based on clinical, surgical, and/or radiographic criteria. RESULTS: Thirteen studies, consisting of 619 patients and 632 MATs and performed from 1984 to 2012, met inclusion criteria. The mean patient age ranged from 24.5 to 43.5 years, with 47% to 87% males and a mean follow-up duration of 11.1 to 20.0 years. Fixation techniques included soft tissue (5 studies), bone plug (6 studies), and bone trough (4 studies). Statistically significant improvements were observed in the Lysholm score (7/9 studies), Tegner score (3/4 studies), VAS score (3/5 studies), and KOOS (1/1 studies). Two studies reported Patient Acceptable Symptom State rates ranging from 70.2% to 71% for Lysholm score and 58.5% to 82% for KOOS. Two studies also reported minimal clinically important difference rates, which ranged from 70.4% to 89.9% for the Lysholm score and 61% to 78.2% for the KOOS subscales. Ten-year MAT survival ranged from 45% to 100%. Most studies (5/9) demonstrated survivorship ≥73% at a minimum 10-year follow-up. MAT survival after ≥15 years ranged from 19% to 87%. CONCLUSION: MAT demonstrated favorable long-term clinical outcomes and variable graft survivorship beyond 10 years. Included studies varied based on graft type, fixation technique, and patient selection. Continued prospective, high-level studies are warranted to standardize surgical approaches, improve the durability of this joint-preserving intervention, and identify modifiable risk factors for inferior long-term outcomes.

来源:Am J Sports Med,查看原文。版权归原作者所有。

引用

  1. Kodra JD, Serkan S, Lee MS, et al. Long-term Outcomes and Survivorship of Meniscal Allograft Transplantation: A Systematic Review With Minimum 10-Year Follow-up. Am J Sports Med. 2026. PMID: 41549414. doi:10.1177/03635465251405494

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。